v3.26.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Non-controlling Interests
Redeemable noncontrolling interests, beginning balance at Dec. 31, 2024 $ 1,158          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Net loss attributable to redeemable noncontrolling interests (1,350)          
Redeemable noncontrolling interests, ending balance at Mar. 31, 2025 (192)          
Balance, beginning of period at Dec. 31, 2024 1,521,199 $ 1,428 $ 754,415 $ 9,737 $ 365,796 $ 389,823
Balance, beginning of period (in shares) at Dec. 31, 2024   142,747,818        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) attributable to Ardent Health, Inc. 41,383       41,383  
Net income attributable to noncontrolling interests 18,932         18,932
Other comprehensive income (loss) (5,809)     (5,809)    
Distributions to noncontrolling interests (19,239)         (19,239)
Equity-based compensation 9,263          
Distributions to noncontrolling interests 9,263          
Vesting of restricted stock unit awards (in shares)   289,946        
Vesting of restricted stock unit awards (1,061) $ 2 (1,063)      
Equity-based compensation     9,263      
Balance, ending of period at Mar. 31, 2025 1,564,668 $ 1,430 762,615 3,928 407,179 389,516
Balance, ending of period (in shares) at Mar. 31, 2025   143,037,764        
Redeemable noncontrolling interests, beginning balance at Dec. 31, 2025 [1] (1,250)          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Net loss attributable to redeemable noncontrolling interests (2,513)          
Redeemable noncontrolling interests, ending balance at Mar. 31, 2026 [1] (3,763)          
Balance, beginning of period at Dec. 31, 2025 $ 1,686,214 [1] $ 1,429 788,472 (3,610) 501,607 398,316
Balance, beginning of period (in shares) at Dec. 31, 2025 142,864,171 142,864,171        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) attributable to Ardent Health, Inc. $ 39,850       39,850  
Net income attributable to noncontrolling interests 21,151         21,151
Other comprehensive income (loss) 1,164     1,164    
Distributions to noncontrolling interests (21,314)         (21,314)
Vesting of restricted stock unit awards (in shares)   275,928        
Vesting of restricted stock unit awards (1,014) $ 2 (1,016)      
Forfeitures of restricted stock awards (in shares)   (6,274)        
Equity-based compensation 8,929   8,929      
Balance, ending of period at Mar. 31, 2026 $ 1,734,980 [1] $ 1,431 $ 796,385 $ (2,446) $ 541,457 $ 398,153
Balance, ending of period (in shares) at Mar. 31, 2026 143,133,825 143,133,825        
[1] As of March 31, 2026 and December 31, 2025, the unaudited condensed consolidated balance sheets included total liabilities of consolidated variable interest entities of
$341.8 million and $335.1 million, respectively. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion.